Financial results - GLYCOSAMED SRL

Financial Summary - Glycosamed Srl
Unique identification code: 37947063
Registration number: J2017004729129
Nace: 8622
Sales - Ron
27.024
Net Profit - Ron
8.907
Employees
1
Open Account
Company Glycosamed Srl with Fiscal Code 37947063 recorded a turnover of 2024 of 27.024, with a net profit of 8.907 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Glycosamed Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 0 1.507 2.828 3.784 5.432 17.114 27.024
Total Income - EUR - - 0 0 1.507 2.828 3.784 5.432 17.114 27.024
Total Expenses - EUR - - 1.581 627 312 473 428 790 9.944 17.388
Gross Profit/Loss - EUR - - -1.581 -627 1.194 2.355 3.356 4.642 7.169 9.636
Net Profit/Loss - EUR - - -1.581 -627 1.149 2.279 3.243 4.512 7.002 8.907
Employees - - 0 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 58.8%, from 17.114 euro in the year 2023, to 27.024 euro in 2024. The Net Profit increased by 1.944 euro, from 7.002 euro in 2023, to 8.907 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Glycosamed Srl

Rating financiar

Financial Rating -
GLYCOSAMED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Glycosamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Glycosamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Glycosamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Glycosamed Srl - CUI 37947063

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 2.454 2.207 1.966 1.735 1.506 1.320 1.127 932
Current Assets - - 16.533 6.402 1.540 3.972 1.274 1.965 10.216 12.612
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 6.355 6.239 0 0 0 0 497 80
Cash - - 10.178 164 1.540 3.972 1.274 1.965 9.719 12.532
Shareholders Funds - - -1.537 -2.136 -7.063 -4.650 -1.304 3.203 10.195 12.082
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 20.525 10.745 10.569 10.357 4.085 83 1.166 1.462
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 12.612 euro in 2024 which includes Inventories of 0 euro, Receivables of 80 euro and cash availability of 12.532 euro.
The company's Equity was valued at 12.082 euro, while total Liabilities amounted to 1.462 euro. Equity increased by 1.944 euro, from 10.195 euro in 2023, to 12.082 in 2024.

Risk Reports Prices

Reviews - Glycosamed Srl

Comments - Glycosamed Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.